This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Exclusive Interviews

Hear from George Church, Ph.D.

George Church, Ph.D., Professor of Genetics, Department of Genetics, Harvard Medical School

In advance of his keynote address at Boston CEO on May 28, Dr. George Church sits down with LeadingBiotech for a fascinating journey through topics including the future of gene editing and its ethical implications, the potential for Blockchain in reconciling patient privacy and data sharing, and the future of the Woolly Mammoth.

Hear from Laurie Glimcher, M.D.

Laurie Glimcher, M.D., President & CEO, Dana-Farber Cancer Institute

Laurie Glimcher is passionate about breakthroughs in cancer research, medical research funding, and the career progression of women. In advance of her fireside chat at Boston CEO on May 28, Laurie sits down with LeadingBiotech to discuss what drives her leadership at Dana-Farber.

Hear from Ed Kaye

Ed Kaye, CEO, Stoke Therapeutics 

Ed Kaye, upcoming speaker at Boston CEO, sits down to talk with LeadingBiotech about his new job as CEO of Stoke Therapeutics, the importance of patient engagement and advocacy in therapeutic development, and advice for new CEOs based on his years of experience in the industry and the incredible relationships he has formed.  

Hear from Andy Plump

Andy Plump, Chief Medical & Scientific Officer, Takeda

In this interview with LeadingBiotech, Andy Plump covers his personal journey as well as the journey of the company since he joined. He also discusses the new frontier in biotech and why Boston truly is the center of it all.

Hear from Paula Soteropolous

Paula Soteropolous, CEO, Akcea

Named one of Massachusetts’ Top 100 Women-Led Businesses, Paula Soteropoulos talks with LeadingBiotech about challenges of rapid company growth, her experiences as a CEO, and the value of gender parity in the boardroom and the workforce in advance of her upcoming participation at Boston CEO 2019.